Bafilomycin a1 b1793
Bafilomycin A1 (B1793) is a laboratory reagent produced by Merck Group. It is a specific inhibitor of vacuolar-type H+-ATPase (V-ATPase).
Lab products found in correlation
25 protocols using bafilomycin a1 b1793
Genetic Murine Models in Tuberculosis Research
Inflammatory Response Modulation Assay
Endothelial Cell Culture and Pharmacological Treatments
Autophagy Marker Antibody Validation
Cell Culture Conditions for HeLa, SCC-13, and HEK293
Diverse Antibody and Reagent Sources
Characterization of HepG2, HepG2-2.15, and Huh-7 Cells
Chemical Reagents Used in Signaling Study
Apoptosis and Autophagy Regulation
Cell Culture and Reagent Protocol
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!